Chronic Liver Disease: New Targets and New Mechanisms
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Mechanisms of Diseases".
Deadline for manuscript submissions: 20 February 2025 | Viewed by 11665
Special Issue Editor
Special Issue Information
Dear Colleagues,
“Chronic liver disease” refers to a disease of the liver lasting more than six months. A large variety of metabolic, viral and autoimmune diseases can cause chronic liver damage. These follow different patterns of liver injury, and can develop into cirrhosis and/or hepatocellular carcinoma.
Although significant advances have been made in preventing liver disease, the global morbidity and mortality rate of liver diseases remains high. It is urgent to determine the molecular and cellular mechanisms underlying the development of chronic liver diseases and to support the development of new therapeutic targets.
This Research Topic welcomes the submission of original research and review articles focusing on the most recent molecular and cellular mechanisms of chronic liver diseases. Submission should cover, but are not limited to, the following sub-topics:
- Novel mechanisms of chronic liver diseases, hepatocellular carcinoma, and cholangiocarcinoma;
- Technology and new tools in the study of chronic liver diseases;
- Novel therapeutic targets for chronic liver diseases;
- Autoimmune Liver Diseases;
- Role of the immune system in non-alcoholic fatty liver disease (NAFLD);
- Potential of immunotherapy for hepatocellular carcinoma (HCC);
- Novel therapeutic approaches to chronic liver diseases;
- Inflammation regulation in chronic liver diseases;
- New biomarkers of liver diseases;
- Liver diseases and cancer.
Dr. Theodoros Androutsakos
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- chronic liver diseases
- autoimmune liver disorders
- metabolic associated fatty liver disease
- hepatocellular carcinoma
- viral hepatitis
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.